| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 273,016 | 245,569 | 455,094 | 1,387,112 | | Cost of Revenue | 47,425 | 160,770 |
-
| 1,080,744 | | | Gross Profit | 225,591 | 84,799 | 455,094 | 306,368 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 79,033 | (30,975) | 143,001 | 70,220 | | Non Recurring | 46,274 | 84,218 |
-
| 274,705 | | Others | 80,113 | 74,009 | 79,750 | 95,598 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,171 | (42,453) | 232,343 | (134,155) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 29,002 | 143,018 | 52,669 | (441,941) | | Earnings Before Interest And Taxes | 60,119 | 119,305 | 289,311 | (571,101) | | Interest Expense | 89,838 | 83,049 | 92,932 | 88,718 | | Income Before Tax | (29,719) | 36,256 | 196,379 | (659,819) | | Income Tax Expense | (9,714) | 3,806 | 15,361 | (568) | | Minority Interest | (162) | (494) | (310) | (8,347) | | | | Net Income From Continuing Ops | (19,201) | 31,956 | 180,708 | (659,251) | | | Non-recurring Events | | Discontinued Operations | 14,748 | 213,278 | 4,393 | (221,462) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,419) | 245,234 | 185,101 | (880,713) | | Preferred Stock And Other Adjustments | (6,369) | (6,369) | (6,369) | (6,352) | | | Net Income Applicable To Common Shares | ($11,788) | $238,865 | $178,732 | ($887,065) |
|
1.52% Nasdaq 
Income Statement
